SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001104659-22-041081
Filing Date
2022-03-31
Accepted
2022-03-31 16:31:17
Documents
1
Period of Report
2021-12-31
Effectiveness Date
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM NT 10-K tm2211100d1_nt10k.htm NT 10-K 23402
  Complete submission text file 0001104659-22-041081.txt   24578
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-36672 | Film No.: 22793082
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences